46,XY DSD due to 17β-Hydroxysteroid Dehydrogenase 3 Deficiency

Genetic Steroid Disorders

Volumn , Issue , 2014, Pages 191-197

  Mendonca, Berenice B ^a   Costa, Elaine M F ^a   Inacio, Marlene ^a   Oliveira Junior, Ari A ^a   Martin, Regina M ^a   Nishi, Mirian Y ^a   Machado, Aline Z ^a   Carvalho, Filomena Marino ^a   Tibor, Francisco Denes ^a   Domenice, Sorahia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

17 hydroxysteroid dehydrogenase 3; 46,XY DSD; Ambiguous genitalia; Gender role; Germ cell tumor; HSD17B3 gene; Testosterone synthesis defect

Indexed keywords

EID: 84902405941     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-416006-4.00013-2     Document Type: Chapter

References (44)

1. Geissler W.M., Davis D.L., Wu L., et al. Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet 1994, 7:34-39.
2. Saez J.M., De Peretti E., Morera A.M., David M., Bertrand J. Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. J Clin Endocrinol Metab 1971, 32:604-610.
3. George M.M., New M.I., Ten S., Sultan C., Bhangoo A. The clinical and molecular heterogeneity of 17betaHSD-3 enzyme deficiency. Horm Res Paediatr 2010, 74:229-240.
4. Lee Y.S., Kirk J.M., Stanhope R.G., et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol 2007, 67:20-28.
5. Mendonca B.B., Inacio M., Arnhold I.J., et al. Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 2000, 79:299-309.
6. Andersson S., Moghrabi N. Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 1997, 62:143-147.
7. Andersson S., Geissler W.M., Wu L., et al. Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 1996, 81:130-136.
8. Boehmer A.L., Brinkmann A.O., Sandkuijl L.A., et al. 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 1999, 84:4713-4721.
9. Mendonca B.B., Domenice S., Arnhold I.J., Costa E.M. 46, XY disorders of sex development. Clin Endocrinol 2009, 70:173-187.
10. Cohen-Kettenis P.T. Gender change in 46, XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 2005, 34:399-410.
11. Rosler A. 17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population. Pediatr Endocrinol Rev 2006, 3(Suppl. 3):455-461.
12. Rosler A., Kohn G. Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role. J Steroid Biochem 1983, 19:663-674.
13. Bertelloni S., Maggio M.C., Federico G., Baroncelli G., Hiort O. 17beta-hydroxysteroid dehydrogenase-3 deficiency: a rare endocrine cause of male-to-female sex reversal. Gynecol Endocrinol 2006, 22:488-494.
14. Ng K.L., Ahmed S.F., Hughes I.A. Pituitary-gonadal axis in male undermasculinisation. Arch Dis Child 2000, 82:54-58.
15. Domenice S. 46,XY Disorders of Sexual Development in website. In New M, ed.:MDTEXT.COM, INC,S.DARTMOUTH, MA;2013. http://www.ENDOTEXT.ORG.
16. Arnhold I.J., Mendonca B.B., Diaz J.A., et al. Prepubertal male pseudohermaphroditism due to 17-ketosteroid reductase deficiency: diagnostic value of a hCG test and lack of HLA association. J Endocrinol Invest 1988, 11:319-322.
17. Ulloa-Aguirre A., Bassol S., Poo J., et al. Endocrine and biochemical studies in a 46, XY phenotypically male infant with 17-ketosteroid reductase deficiency. J Clin Endocrinol Metab 1985, 60:639-643.
18. Rosler A., Silverstein S., Abeliovich D.A. (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 1996, 81:1827-1831.
19. Labrie F., Luu-The V., Lin S.X., et al. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997, 62:148-158.
20. Labrie F., Luu-The V., Lin S.X., Simard J., Labrie C. Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Trends Endocrinol Metab 2000, 11:421-427.
21. Werner R., Kulle A., Sommerfeld I., et al. Testosterone synthesis in patients with 17beta-hydroxysteroid dehydrogenase 3 deficiency. Sex Dev 2012, 6:161-168.
22. Bruening W., Bardeesy N., Silverman B.L., et al. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat Genet 1992, 1:144-148.
23. Rogers D.G., Chasalow F.I., Blethen S.L. Partial deficiency in 17-ketosteroid reductase presenting as gynecomastia. Steroids 1985, 45:195-200.
24. Castro-Magana M., Angulo M., Uy J. Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase. N Engl J Med 1993, 328:1297-1301.
25. Mains L.M., Vakili B., Lacassie Y., Andersson S., Lindqvist A., Rock J.A. 17beta-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite. Fertil Steril 2008, 89(228):e13-e17.
26. Imperato-McGinley J., Peterson R.E., Stoller R., Goodwin W.E. Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J Clin Endocrinol Metab 1979, 49:391-395.
27. Alikasifoglu A., Hiort O., Gonc N., Demirbilek H., Isik E., Kandemir N. 17beta-hydroxysteroid dehydrogenase type 3 deficiency as a result of a homozygous 7 base pair deletion in 17betaHSD3 gene. J Pediatr Endocrinol Metab 2012, 25:561-563.
28. Bertelloni S., Balsamo A., Giordani L., et al. 17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence. J Endocrinol Invest 2009, 32:666-670.
29. Omrani M.D., Adamovic T., Grandell U., Saleh-Gargari S., Nordenskjold A. 17-beta-hydroxysteroid dehydrogenase type 3 deficiency in three adult Iranian siblings. Sexual development: genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation. Sex Dev 2011, 5:273-276.
30. Rosler A., Belanger A., Labrie F. Mechanisms of androgen production in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 1992, 75:773-778.
31. Cools M., Drop S.L., Wolffenbuttel K.P., Oosterhuis J.W., Looijenga L.H. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006, 27:468-484.
32. Cools M., van Aerde K., Kersemaekers A.M., et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. J Clin Endocrinol Metab 2005, 90:5295-5303.
33. Wunsch L., Holterhus P.M., Wessel L., Hiort O. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis. BJU Int 2012, 110:E958-E965.
34. Looijenga L.H., Oosterhuis J.W. Pathobiology of testicular germ cell tumors: views and news. Anal Quant Cytol Histol 2002, 24:263-279.
35. Looijenga L.H., Stoop H., de Leeuw H.P., et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003, 63:2244-2250.
36. Looijenga L.H., Hersmus R., Oosterhuis J.W., Cools M., Drop S.L., Wolffenbuttel K.P. Tumor risk in disorders of sex development (DSD). Best practice & research. J Clin Endocrinol Metab 2007, 21:480-495.
37. Lee P.A. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006, 118:e488-e500.
38. Hughes I.A., Houk C., Ahmed S.F., Lee P.A. Consensus statement on management of intersex disorders. Arch Dis Child 2006, 91:554-563.
39. Siminas S., Kokai G., Kenny S.E. Complete androgen insensitivity syndrome associated with bilateral sertoli cell adenomas and paratesticular leiomyomas: Case report and review of the literature. J Pediatr Urol 2013, 9:E31-E34.
40. Auchus R.J., Miller W.L. Defects in androgen biosynthesis causing 46, XY disorders of sexual development. Semin Reprod Med 2012, 30:417-426.
41. Bilbao J.R., Loridan L., Audi L., Gonzalo E., Castano L. A novel missense (R80W) mutation in 17-beta-hydroxysteroid dehydrogenase type 3 gene associated with male pseudohermaphroditism. Eur J Endocrinol 1998, 139:330-333.
42. Inacio M., Sircili M.H., Brito V.N., et al. 46, XY DSD due to 17beta-HSD3 deficiency and 5alpha-reductase type 2 deficiency. Adv Exp Med Biol 2011, 707:9-14.
43. Mc Keever K.H. The endocrine system and the challenge of exercise. The Veterinary Clinics of North America Equine Practice 2002, 18:321-353. vii.
44. Mendonca B.B., Arnhold I.J., Bloise W., Andersson S., Russell D.W., Wilson J.D. 17Beta-hydroxysteroid dehydrogenase 3 deficiency in women. J Clin Endocrinol Metab 1999, 84:802-804.